Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics.

Liver fibrosis represents a serious worldwide health issue with a prevalence of around 5% in general populations.1 The most ...

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in ...

Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used ...

The cells that line the inside of the gut may play a key role in triggering inflammation that drives MS, a study found.

Bionxt has completed manufacturing of a batch of BNT23001, its under-the-tongue formulation of cladribine, for use in MS ...

Aging does not arrive all at once. It builds quietly across years, touching cells long before symptoms appear.

This review focuses on patient care tips and practices for the care of patients with B-NHL or MM receiving bispecific antibody therapy.

What causes autoimmune disease? A new study finds that somatic mutations in immune checkpoint genes like PDL1 trigger the ...

MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that it ...